Enhancement of Cell-Mediated Immunity Against HIV-1 Induced by Coinoculation of Plasmid-Encoded HIV-1 Antigen with Plasmid Expressing IL-12 1

Journal of Immunology

Volumn 158, Issue 8, 1997, Pages 4008-4013

  Tsuji, Takashi ^a   Hamajima, Kenji ^a   Fukushima, Jun ^a   Xin, Ke Qin ^a   Ishii, Norihisa ^a   Aoki, Ichiro ^a   Ishigatsubo, Yoshiaki ^a   Tani, Kenji ^a   Kawamoto, Susumu ^a   Nitta, Yoshio ^b   Miyazaki, Jun Ichi ^b   Koff, Wayne C ^c   Okubo, Takao ^a   Okuda, Kenji ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c United Biomedical Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 12;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELLULAR IMMUNITY; FEMALE; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; IMMUNOLOGY; MOUSE; PLASMID;

AIDS VACCINES; ANIMALS; FEMALE; HIV ANTIGENS; HIV-1; HUMANS; IMMUNITY, CELLULAR; IMMUNIZATION; INTERLEUKIN-12; MICE; MICE, INBRED BALB C; PLASMIDS;

EID: 0031569459     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Carmichael, A., X. Jin, P. Sissons, and L. Borysiewics. 1993. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177:249.
2. Langlade-Demoyen, P., N. Ngo-Giang-Huong, F. Ferchal, and E. Oksenhendler. 1994. HIV nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. J. Clin. Invest. 93:1293.
3. Rowland-Jones, S., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, M. Takiguchi, T. Schultz, A. McMichael, and H. Whittle. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian woman. Nat. Med. 1:59.
4. Okuda, K., T. Kaneko, T. Yamakawa, S. Tanaka, I. Aoki, K. Hamajima, and S. Kawamoto. 1993. Strong synergistic effects of multicomponent vaccine for human immunodeficiency virus infection. J. Clin. Lab. Immunol. 40:97.
5. Okuda, K., T. Kaneko, T. Yamakawa, S. Tanaka, T. Shigematsu, A. Yamamoto, K. Hamajima, K. Nakajima, S. Kawamoto, and P. Phanuphak. 1993. Strong immunogenicity of a multicomponent peptide vaccine developed with the branched lysin oligopeptide method for human immunodeficiency virus infection. J. Mol. Recognit. 6:101.
6. Bukawa, H., K. Sekigawa, K. Hamajima, J. Fukushima, Y. Yamada, H. Kiyono, and K. Okuda. 1995. Neutralizing of HIV-1 by secretory IgA induced by oral immunization with a macromolecular multicomponent peptide vaccine candidate. Nat. Med. 1:681.
7. Bukawa, H., J. Fukushima, K. Hamajima, M. Kimura, T. Tsuji, K.-Q. Xin, and K. Okuda. 1995. Antibody responses raised against a conformational V3 loop peptide of HIV-1. Microbiol. Immunol. 39:607.
8. Okuda, K., H. Bukawa, K. Hamajima, S. Kawamoto, K. Sekigawa, Y. Yamada, S. Tanaka, N. Ishii, I. Aoki, M. Nakamura, H. Yamamoto, B. R. Cullen, and J. Fukushima. 1995. Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV-1 em and rev gene products. AIDS Res. Hum. Retroviruses 11:933.
9. Clerici, M., and G. M. Shearer. 1993. A Th1-Th2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14:107.
10. Shearer, G. M., and M. Clerici. 1996. Protective immunity against HIV infection: has nature done the experiment for us? Immunol. Today 17:21.
11. Trinchieri, G. 1994. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008.
12. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827.
13. Bloom, E. T., and J. A. Horvath. 1994. Cellular and molecular mechanisms of the IL-12-induced increase in allospecific murine cytolytic T cell activity: implications for the age-related decline in CTL. J. Immunol. 152:4242.
14. Variante, N. M., M. Rengaraju, and G. Trinchieri. 1992. Role of the production of natural killer cell stimulatory factor (NKSF/IL-12) in the ability of the B cell lines to stimulate T and NK cell proliferation. Cell. Immunol. 145:187.
15. Gately, M. K., B. B. Desai, A. G. Wolitzky, P. M. Quinn, C. M. Dwyer, and F. J. Podlaski. 1991. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J. Immunol. 147:874.
16. + T cells. J. Immunol. 151:1938.
17. + T cells from αβ-TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-γ production is IFN-γ-dependent. Int. Immunol. 5:1119.
18. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505.
19. Wynn, T. A., D. Jankovic, S. Hienty, A. W. Cheever, and A. Sher. 1995. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decrease T helper 2 cytokine expression, IgE production, and tissue eosinophilia. J. Immunol. 154:4701.
20. Gazzinelli, R. T., N. A. Giese, and H. C. Morse III. 1994. In vivo treatment of interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS). J. Exp. Med. 180:2199.
21. Clench, M., D. R. Lucey, J. A. Berzofsky, L. A. Pinto, T. A. Wynn, S. P. Blatt, M. J. Dolan, C. W. Hendrix, S. F. Wolf, and G. M. Shearer. 1993. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 262:1721.
22. Kaufman, R. J., M. V. Davies, L. C. Wasley, and D. Michnick. 1991. Improved vectors for stable expression of foreign genes in mammalian cells by use of the untranslated leader sequence from EMC virus. Nucleic Acids Res. 19:4485.
23. Niwa, H., K. Yamamura, and J. Miyazaki. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193.
24. Okuda, K., S. S. Twining, C. S. David, and M. Z. Atassi. 1979. Genetic control of immune response to sperm whale myoglobin in mice. J. Immunol. 123:182.
25. Brunda, M. J., L. Luistro, R. R. Warrier, R. B. Wright, B. R. Hubbard, M. Murphy, S. F. Wolf, and M. K. Gately. 1993. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 178:1223.
26. Tahara, H., L. Zitvogel, W. J. Storkus, H. J. Zeh III, T. G. Mckinney, R. D. Schreiber, U. Gubler, P. D. Robbins, and M. T. Lotze. 1995. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J. Immunol. 154:6466.
27. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Feigner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, L. A. Hawe, K. R. Leander, D. Martinez, H. C. Perry, J. W. Shiver, D. L. Montgomery, and M. A. Liu. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745.
28. Wang, B., K. E. Ugen, V. Srikantan, M. G. Agadjanyan, K. Dang, Y. Refaeli, A. I. Sato, J. Boyer, W. V. Williams, and D. B. Weiner. 1993. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90:4156.
29. Xiang, Z. Q., S. Spitalnik, M. Tran, W. H. Wunner, J. Cheng, and H. C. J. Ertl. 1994. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199:132.
30. Yokohama, M., J. Zhang, and J. L. Whitton. 1995. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J. Virol. 69:2684.
31. Corr, M., D. J. Lee, D. A. Carson, and H. Tighe. 1996. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 184:1555.
32. + suppressor T cells with human immunodeficiency virus (HIV)-specific cellular cytotoxicity and natural killer cell activity in HIV infection. Immunology 74:567.
33. Clench, M., J. V. Giorgi, C.-C. Chou, V. K. Gudeman, J. A. Zack, P. Gupta, H.-N. Ho, P. G. Nishanian, J. A. Berzofsky, and G. M. Shearer. 1992. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J. Infect. Dis. 165:1012.
34. + T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc. Natl. Acad. Sci. USA 92:2308.
35. + cell clones derived from HIV-infected and uninfected individuals. Cell. Immunol. 159:271.
36. + cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection by an HLA-unrestricted mechanism. J. Immunol. 153:4826.
37. Ling, P., M. K. Gately, U. Gubler, A. S. Stern, P. Lin, K. Hollfelder, C. Su, Y.-C. E. Pan, and J. Hakimi. 1995. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J. Immunol. 154:116.
38. Zou, J.-P., N. Yamamoto, T. Fujii, H. Takenaka, M. Kobayashi, S. H. Herrmann, S. F. Wolf, H. Fujiwara, and T. Hamaoka. 1995. Systemic administration of rIL-12 induces completely tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-γ production by anti-tumor T cells. Int. Immunol. 7:1135.
39. Schijns, V. E. C. J., B. L. Haagmans, and M. C. Horzinek. 1995. IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-γ-receptor-deficient mice. J. Immunol. 155:2525.
40. Chehimi, J., S. E. Starr, I. Frank, A. D'Andrea, X. Ma, R. R. MacGregor, J. Sennelier, and G. Trinchieri. 1994. Impaired interleukin-12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179:1361.
41. Chehimi, J., S. E. Starr, I. Frank, M. Rengaraju, S. J. Jackson, C. Lanes, M. Kobayashi, B. Perussia, D. Young, E. Nickbarg, S. F. Wolf, and G. Trinchieri. 1992. Natural killer (NK) stimulatory factor increses the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J. Exp. Med. 175:789.
42. Radrizzani, M., P. Accornero, A. Amidei, A. Aiello, D. Delia, R. Kurrle, and M. P. Colombo. 1995. IL-12 inhibits apoptosis induced in a human Th1 clone by gp120/CD4 cross-linking and CD3/TCR activation or by IL-2 deprivation. Cell. Immunol. 161:14.
43. + T cells from human immunodeficiency virus-infected persons. J. Exp. Med. 182:1759.
44. Wolff, J. A., R. W. Malone, P. Williams, W. Chong, G. Acsadi, A. Jani, and P. L. Feigner. 1990. Direct gene transfer into mouse muscle in vivo. Science 247:1465.
45. Xiang, Z. Q., S. L. Spitalnik, J. Cheng, J. Erikson, B. Wojczyk, and H. C. J. Ertl. 1995. Immune responses to nucleic acid vaccines to rabies virus. Virology 209: 569.
46. Xiang, Z. Q., and H. C. J. Ertl. 1995. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmid expressing cytokines. Immunity 2:129.
47. Tsuji, T., J. Fukushima, K. Hamajima, N. Ishii, I. Aoki, H. Bukawa, Y. Ishigatsubo, K. Tani, T. Okubo, M. E. Dorf, and K. Okuda. 1997. HIV-1-specific cell-mediated immunity is enhanced by coinoculation of TCA3 expression plasmid with DNA vaccine. Immunology 90:1.